I have tried to find comparable examples, but with little success. Best I could find was a company being taken over primarily for 1 drug that was seen as a possible block buster.
It was very late in the trial process, so it had been as about as de-risked as you could hope for [Refer RA's comments about waiting] and the price paid was 3 times the estimated revenue that would be generated. The IPO in 2009 was around $150 million US dollars, Not sure how much patent time was left.
So Monepantel as a drug could make the owner ??? Patents start to expire starting 2032 for Canine/Human cancer and 2040 for antiviral. So a reasonably long runway for a company to get their money back.
Remember RA has said he thinks 1 company will take all the licenses. Not sure if he was including the Doggies in that.
Does anyone have any evidence of similar situations ?
Pete
- Forums
- ASX - By Stock
- PAA
- Ann: AGM Presentation
Ann: AGM Presentation, page-63
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
21.5¢ | 21.5¢ | 20.5¢ | $168.6K | 813.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 144453 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 0.205 |
9 | 403445 | 0.200 |
7 | 254593 | 0.195 |
13 | 539478 | 0.190 |
25 | 1074698 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 144453 | 3 |
0.215 | 176899 | 4 |
0.220 | 180489 | 4 |
0.225 | 2566 | 1 |
0.230 | 51179 | 1 |
Last trade - 15.05pm 12/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |